BioMarin Pharmaceuticals
BMRN
BMRN
557 hedge funds and large institutions have $13.7B invested in BioMarin Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 80 funds opening new positions, 195 increasing their positions, 194 reducing their positions, and 68 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.21% more ownership
Funds ownership: 96.5% → 96.71% (+0.21%)
13% less capital invested
Capital invested by funds: $15.6B → $13.7B (-$1.97B)
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
Holders
557
Holding in Top 10
6
Calls
$116M
Puts
$70.2M
Top Buyers
| 1 | +$208M | |
| 2 | +$68M | |
| 3 | +$60.6M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$56.5M |
| 5 |
HM
HealthCor Management
New York
|
+$47M |
Top Sellers
| 1 | -$253M | |
| 2 | -$243M | |
| 3 | -$104M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$93.4M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$40.2M |